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INTRODUCTION
Streptococcus bovis is a member of group D streptococci-
common inhabitants of the intestine and causative agents
of endocarditis. A well-recognized association has been
established between S. bovis endocarditis and colon carci-
noma, which led to great interest in the identification of
this organism [1]. The S. bovis group is divided into 3 bio-
types according to their biochemical characteristics: bio-
type I (mannitol fermentation positive), biotype II/1 (man-
nitol negative and b-glucuronidase negative), and biotype
II/2 (mannitol negative and b-glucuronidase positive) [2].
Each biotype has somewhat different pathogenicity. S.
bovis biotype I has been documented to be the biotype
more likely associated with both endocarditis and malig-
nant or premalignant colonic lesions [3]. The taxonomy of
the S. bovis group has been evolving in the last few decades,
and a new nomenclature was adopted on the basis of genetic
distances and phylogenetic analyses. The new classifica-
tion lists S. bovis biotypes I, II/1, and II/2 as Streptococcus
gallolyticus subsp. gallolyticus, Streptococcus infantarius
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subsp. coli, and S. gallolyticus subsp. pasteurianus, respec-
tively [4]. We report a case of infective endocarditis with
colon cancer caused by S. gallolyticus subsp. gallolyticus.
Identification of the causative organism was performed by
phenotypic characterization and 16S rDNA sequence anal-
ysis.
CASE REPORT
A 59-yr-old woman was admitted to Seoul National
University Hospital, with a 1-month history of recurrent
episodes of fever and chills. She also had arthralgia of both
knees and 3 episodes of fecal incontinence for 1 month. She
was a carrier of the hepatitis C virus and had a history of
stage 4 gastric marginal zone lymphoma, which had been
previously treated with chemotherapy over 2 yr ago. She
had no evidence of residual lymphoma after treatment. On
physical examination, fever was present (38.9℃); lung fields
were clear; heart sounds were regular without murmur;
and abdomen was soft, non-distended, and with no pal-
pable mass. Digital rectal examination revealed no mele-
na, hematochezia, or mass. Specimens for laboratory tests
and blood cultures were collected, and empirical antibiotic
therapy with intravenous ciprofloxacin (400 mg every 12
hr) was started. Initial laboratory studies showed the fol-
lowing results: hemoglobin (11.1 g/dL), white blood cells
[12.01×109/L; neutrophils (79%), lymphocytes (14%), and
monocytes (4%)], platelets (242×109/L), and C-reactive pro-
tein (5.79 mg/dL). Results of the liver function tests and
creatinine, glucose, and troponin tests were within the
normal range. Stool occult blood test was not performed.
The patient’s chest radiograph was unremarkable. She had
persistent fever increasing up to 39.1℃ despite antibiotic
therapy, and initial blood cultures were positive for gram-
positive cocci in pairs and short chains. Twenty-four hours
later, ciprofloxacin was discontinued and vancomycin (1,000
mg every 12 hr) was started after collecting additional blood
cultures. An echocardiography was performed, which show-
ed vegetations on the mitral and aortic valves. The initial
isolate from the first blood cultures was identified as S.
gallolyticus subsp. gallolyticus, which was susceptible to
penicillin. The second blood cultures were also positive for
similar alpha-hemolytic streptococci. Vancomycin was dis-
continued and antibiotics were replaced by intravenous
penicillin G (3,000,000 U every 4 hr) and gentamicin (63 mg
every 8 hr). The fever subsided, and the subsequent blood
cultures were negative for streptococci. The isolate from
the second blood cultures was initially identified as Strep-
tococcus mutans; however, the results of retest and fur-
ther investigation confirmed that it was the same strain
as the isolate from the first blood cultures. The results of
blood cultures were discussed among clinical microbiolo-
gists and physicians, including the corrected results of the
second blood cultures, the information about the causative
organism (i.e., S. gallolyticus subsp. gallolyticus, which was
named as S. bovis biotype I in the previous nomenclature
system), and the risk of colon cancer. The abdomen com-
puterized tomography (CT) image showed newly detected
segmental wall thickening of the sigmoid colon. Colono-
scopy revealed an ulceroinfiltrative mass, which was con-
firmed as adenocarcinoma. The patient underwent opera-
tion for valve replacement and anterior resection for colon
cancer on the 18th and 50th day of hospitalization, respec-
tively. She successfully recovered and was discharged after
completing the antibiotic therapy and postoperative care.
Both the first and the second blood cultures showed
gram-positive cocci in pairs and short chains after 24 hr of
incubation in broths at 37℃ (Bactec, Becton Dickinson,
Baltimore, MD, USA). Subsequent subculture on 5% sheep
blood and chocolate agars incubated at 35℃ showed small
alpha-hemolytic colonies. The isolates were negative for
catalase and pyrrolidonylarylaminidase, showed no zone
of inhibition around the optochin disk, failed to grow in
heart infusion broth containing 6.5% NaCl, and bile-esculin
positive after overnight incubation. A tentative identifica-
tion of viridans group Streptococcus was made. The Vitek2
GP identification system (bioMe@rieux, Durham, NC, USA)
was used to identify the isolate from the first blood culture
as S. gallolyticus subsp. gallolyticus; the isolate from the
second culture was identified as S. mutans. The tests were
repeated twice for the subculture of the second isolate, and
the results were as follows: S. gallolyticus subsp. gallolyti-
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cus (excellent identification, probability 98.11%), S. gal-
lolyticus subsp. gallolyticus (low discrimination, 50.52%),
and S. mutans (49.48%). Both of the repeated tests showed
identical biochemical profiles, except that the test with an
excellent confidence level showed a positive result in the
pullulan acidification test. The API 20 Strep system (bio-
Me@rieux, Durham, NC, USA) identified the isolate from
the first blood culture as S. bovis biotype I (S. gallolyticus
subsp. gallolyticus) (profile 5000453, 78.1%) and S. bovis
biotype II (13.5%), while the isolate from the second culture
was identified as S. bovis biotype I (S. gallolyticus subsp.
gallolyticus) (profile 5000553, 99.1%). The first isolate show-
ed negative reactions with leucine arylamidase and man-
nitol, which are atypical for S. gallolyticus subsp. gallolyti-
cus. The subculture of the first isolate was tested repeat-
edly and identified by the API 20 Strep system as S. gal-
lolyticus subsp. gallolyticus, with 99.1% probability. The
biochemical profiles of this strain are compared with those
of the S. gallolyticus and S. infantarius subspecies in Table
1. Antimicrobial susceptibility testing was performed by E
test for penicillin and disk diffusion methods for other anti-
biotics. Isolates from the first and second blood cultures
showed identical results: susceptible to penicillin (MIC=
0.032 mg/mL), vancomycin, and chloramphenicol and resis-
tant to erythromycin and clindamycin.
We performed 16S rDNA gene sequencing for the isolates
from the first and second blood cultures. The forward (27F:
5′-AGAGTTTGATCMTGGCTCAG-3′) and reverse (1492R:
5′-TACGGYTACCTTGTTACGACTT-3′) primers were used
to amplify 16S rDNA gene fragments, representing approx-
imately 98% of the complete 16S rDNA gene. The following
primers were used for sequencing of the fragments obta-
ined: 27F, 518F (5′-CCAGCAGCCGCGGTAATACG-3′) and
800R (5′-TACCAGGGTATCTAATCC-3′). Both isolates
showed identical 16S rDNA gene sequences and showed
100% (1,480/1,480 bp) homology with those of S. gallolyti-
cus subsp. gallolyticus (EU163500, GenBank). Isolates from
the first and second blood cultures showed 99.7% (1,476/
1,480 bp) and 98.6% (1,459/1,480 bp) homology with S. gal-
lolyticus subsp. pasteurianus (EU163502, GenBank) and S.
infantarius subsp. coli (EU163503, GenBank), respectively
[5]. The sequences were analyzed by using MicroSeq ID 16S
rDNA 500 library v2.1 and analysis software v2.0 (Applied
Biosystems, Foster City, CA, USA), and the isolate was
*The biochemical profiles of the subspecies of S. gallolyticus and S. infantarius were obtained from a report by Schlegel et al. [4].
Abbreviations: NT, not tested; +, ≥80% of strains positive; -, ≤20% of strains positive; v, 21-79% activity compared to the positive control reaction.
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Esculin NT + + + - v +
Production of:
b-Glucosidase NT + + + - v +
b-Glucuronidase - - - + - - -
a-Galactosidase + - + v v + +
b-Galactosidase - - - + v - -
Acidification of:
Starch NT + + - + + v
Glycogen NT + + - - + -
Inulin NT - + - - - -
Lactose + + + + + + +
Mannitol + + + - - - -
Methyl-b-D-glucopyranoside + NT + + - - +
Raffinose + + + v - + -
Trehalose + + + + - - -
Table 1. Characteristics of the blood culture isolates of this case in comparison with the subspecies of Streptococcus gallolyticus and
Streptococcus infantarius
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identified as S. bovis.
DISCUSSION
The relationship between streptococcal endocarditis and
colon cancer was first described in 1951 [6], and S. bovis
was recognized as the pathogen specifically related to colon
cancer in 1977 [1]. Although many other bacterial strains
have been associated with gastrointestinal tumors, the
association between S. bovis and colon cancer remains the
strongest and best documented one. Several prospective
studies have suggested that S. bovis infection could be seen
as a first sign of colon cancer [7, 8]. Therefore, clinicians
should not readily rule out colon cancer or other malignan-
cies when they encounter patients with S. bovis infection.
In this case, colon cancer can be detected by colonoscopy
upon clinical suspicion of S. bovis infection, even without
clinical findings suggesting colon cancer. The pathogene-
sis of the association between S. bovis infection and colon
neoplasms has been widely investigated; however, the pa-
thogenesis is still not clear. One hypothesis is that the S.
bovis group is a normal inhabitant of the gastrointestinal
tract and can readily enter the bloodstream upon mucosal
disruption or vascular changes [9].
Since the early 1980s, genetic and biochemical diversi-
ties among S. bovis bacteria have been recognized. These
diversities led to devising schemes to distinguish strains
by biotype. S. bovis bacteria are said to be biotype I (or typ-
ical) if they ferment mannitol and produce glucan, and
biotype II (or variant) if they cannot ferment mannitol or
produce glucan. The S. bovis biotype II strains are further
divided into types II/1 and II/2 according to the ability of
the latter group to produce b-galactosidase and b-glucu-
ronidase and ferment trehalose but not glycogen [10]. In
the 1990s, 4 new species were described: Streptococcus
gallolyticus, Streptococcus macedonicus, Streptococcus
waius, and Streptococcus infantarius [11]. S. gallolyticus,
originally isolated from koalas, is phenotypically similar to
S. bovis biotype I [12], and reexamination of strains previ-
ously identified as S. bovis by either phenotypic or genetic
methods revealed that many of the human strains associ-
ated with endocarditis and animal (goat, pigeon, and cow)
strains are identical to S. gallolyticus [13, 14]. Meanwhile,
molecular technologies, such as DNA-DNA hybridization
or the amplification of selected targets, have been devel-
oped to complement and improve the identification of strep-
tococci at the species level. Farrow et al. demonstrated that
the S. bovis/Streptococcus equinus complex comprised 6
DNA groups [15]. Members of DNA group 2 have been re-
classified, according to their genetic and biochemical char-
acteristics, and renamed as S. gallolyticus subsp. gallolyti-
cus, S. gallolyticus subsp. pasteurianus, or S. gallolyticus
subsp. macedonicus [4]. Biochemical characteristics, such
as gallate hydrolysis activity, are useful for the identifica-
tion at the subspecies level. A recent study showed that
the published phenotypic characteristics of S. gallolyticus
and S. infantarius were equivocal and did not allow unam-
biguousphenotypic differentiation [5]. Beck et al. also show-
ed that although the 16S rDNA gene sequences are very
similar between subspecies, full-length 16S rDNA gene
sequence analysis clearly assigned the subspecies in most
cases because of the extremely low base pair variability
within one species or subspecies. They showed that only 3
of 29 S. gallolyticus subsp. gallolyticus strains, 1 of 12 S.
gallolyticus subsp. pasteurianus strains, and 1 of 17 S. in-
fantariuss subsp. coli had single point mutations, whereas
other strains showed identical 16s rDNA sequences within
each subspecies [5]. Our isolates did not ferment inulin but
fermented mannitol and raffinose. They also produced acid
from starch, glycogen, methyl-b-D-glucopyranoside, and
trehalose, but did not produce b-glucuronidase and b-gal-
actosidase (Table 1). On the basis of the biochemical char-
acteristics and the 16S rDNA sequencing data, we could
identify the infecting organism as S. gallolyticus subsp.
gallolyticus with high confidence at the subspecies level.
Cases of S. bovis infection associated with underlying
malignancies have been rarely reported in Korea. There
are 2 previous reported cases of S. bovis endocarditis and
associated colon cancer in Korea [16, 17]; however, they
did not provide information about the microbiological char-
acteristics or S. bovis biotypes. In a more recent single-
center study, the association of S. bovis biotypes with the
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type of clinical infection and data on antimicrobial suscep-
tibility was studied. In this study, none of the 13 patients
with S. bovis bacteremia had gastrointestinal malignan-
cies [18]. More studies on the prevalence, underlying dis-
eases, and microbiological characteristics of S. gallolyticus
subspecies in Korea are needed.
This case shows that accurate identification of S. gal-
lolyticus subsp. gallolyticus endocarditis makes the detec-
tion of underlying cancer possible. Much attention should
be given when identifying the causative organisms of strep-
tococcal endocarditis, and investigation for underlying gas-
trointestinal malignancies should be performed when S.
gallolyticus is identified. In addition, some clinicians may
not be familiar with the new nomenclature system of S.
bovis bacteria. This lack of awareness can lead to under-
diagnosis of serious underlying conditions, including colon
cancer; thus, it is important to provide clinicians with suf-
ficient information about the nomenclature change when
reporting study results. Moreover, although the use of the
name S. bovis biotype I or II/2 instead of S. gallolyticus is
common in clinical microbiology despite the clearly estab-
lished new nomenclature, it is also important to update
and use the proper taxonomic species in reporting, com-
munication, or clinical studies to prevent further confu-
sion in the future.
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